INTERNATIONAL PATENT: RINUAGENE BIOTECHNOLOGY CO., LTD., RINUAGENE INTERNATIONAL HK LIMITED FILES APPLICATION FOR "HUMAN PAPILLOMA VIRUS (HPV) MRNA VACCINES AND USES THEREOF"

GENEVA, Aug. 10 -- RINUAGENE BIOTECHNOLOGY CO., LTD. (Unit 201, Building 24, Zone C, Suzhou Biomedical Industrial Park (Phase II), 218 Sangtian Street, Suzhou Industrial Park, Suzhou Zone of China (Jiangsu) Pilot Free Trade ZoneSuzhou, Jiangsu 215000), RINUAGENE INTERNATIONAL HK LIMITED (Suite 603, 6/F., Laws Commercial Plaza, 788 Cheung Sha Wan Road, KowloonHong Kong 999077) filed a patent application (PCT/CN2025/073829) for "HUMAN PAPILLOMA VIRUS (HPV) MRNA VACCINES AND USES THEREOF" on Jan 22, 2025. With publication no. WO/2025/162105, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by t...